These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 30634629

  • 1. High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
    Xie L, Dang Y, Guo J, Sun X, Xie T, Zhang L, Yan Z, Amin H, Guo X.
    Genes (Basel); 2019 Jan 10; 10(1):. PubMed ID: 30634629
    [Abstract] [Full Text] [Related]

  • 2. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec 10; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 3. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018 Dec 10; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 4. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
    Wang W, He J, Lu H, Kong Q, Lin S.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32519739
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y, Jiang L, Lin H, Li X, Long X, Zhou Y, Li B, Li Z.
    IUBMB Life; 2019 Jul 31; 71(7):942-955. PubMed ID: 30817091
    [Abstract] [Full Text] [Related]

  • 6. UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.
    Hou L, Li Y, Wang Y, Xu D, Cui H, Xu X, Cong Y, Yu C.
    Dis Markers; 2018 Jul 31; 2018():4108919. PubMed ID: 30420903
    [Abstract] [Full Text] [Related]

  • 7. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D, Luo L, Liang C.
    PLoS One; 2018 Jul 31; 13(5):e0197402. PubMed ID: 29746588
    [Abstract] [Full Text] [Related]

  • 8. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S, Wang P, Su X, Chen J, Chen H, Yang H, Fang A, Xie L, Yao Y, Yang J.
    PLoS One; 2017 Jul 31; 12(10):e0187356. PubMed ID: 29088286
    [Abstract] [Full Text] [Related]

  • 9. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L, Wang H, Wei D, Wang B, Zhang C, Zhu T, Ma Z, Li Z, Wu Y, Yu G.
    PLoS One; 2020 Jul 31; 15(5):e0233283. PubMed ID: 32437446
    [Abstract] [Full Text] [Related]

  • 10. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
    Su X, Wan Y, Xie L, Lin X, Zhao H, Ju X, Fang A.
    Med Sci Monit; 2019 Sep 06; 25():6691-6701. PubMed ID: 31489957
    [Abstract] [Full Text] [Related]

  • 11. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M, Jiang Q, Jin R.
    IUBMB Life; 2018 Jul 06; 70(7):670-677. PubMed ID: 29667299
    [Abstract] [Full Text] [Related]

  • 12. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C, Hou L, Cui H, Zhang L, Tan X, Leng X, Li Y.
    Future Oncol; 2018 Oct 06; 14(24):2483-2492. PubMed ID: 29756998
    [Abstract] [Full Text] [Related]

  • 13. PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
    Zhang W, Li T, Hu B, Li H.
    Technol Cancer Res Treat; 2020 Oct 06; 19():1533033820957030. PubMed ID: 33084541
    [Abstract] [Full Text] [Related]

  • 14. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y, Wang M, Liu B.
    J Cell Physiol; 2019 Apr 06; 234(4):4454-4459. PubMed ID: 30317601
    [Abstract] [Full Text] [Related]

  • 15. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun 06; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 16. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
    Liu S, Tian W, Li B.
    Comput Biol Chem; 2022 Feb 06; 96():107603. PubMed ID: 34894606
    [Abstract] [Full Text] [Related]

  • 17. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A, Ding S, Shen X, Lin X.
    Comput Math Methods Med; 2021 Feb 06; 2021():9932088. PubMed ID: 34367321
    [Abstract] [Full Text] [Related]

  • 18. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F, Zhang L, Ren Y, Ma Q.
    J Cell Physiol; 2019 Jul 06; 234(7):10918-10925. PubMed ID: 30549039
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT, Lin YC, Xiao BF, Yu BT.
    Med Sci Monit; 2019 Jun 08; 25():4264-4272. PubMed ID: 31175804
    [Abstract] [Full Text] [Related]

  • 20. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.